Healthcare Economics and Government Affairs, Medtronic Korea Ltd, Seoul, South Korea; Department of Pharmaceutical Medicine and Regulatory Science, College of Medicine and Pharmacy, Yonsei University, Seoul, South Korea.
Global Health Policy, Medtronic Australasia Pty Ltd, Sydney, NSW, Australia.
Value Health Reg Issues. 2023 Jul;36:27-33. doi: 10.1016/j.vhri.2023.02.002. Epub 2023 Apr 3.
The introduction of digital health technologies (DHTs) that have the potential to improve health outcomes and lower the costs of healthcare services has seen an explosion in recent years. Indeed, the expectation that these innovative technologies can ultimately fill a gap in the patient-healthcare provider model of care with the hope of bending the continuously increasing healthcare expenditure curve has not yet been realized in many countries including South Korea (from herein referred to as Korea). We examine reimbursement coverage decision making status for DHTs in South Korea.
We examine the regulatory landscape, health technology assessment process, and reimbursement coverage determination for DHTs in Korea.
We identified the specific challenges and opportunities for reimbursement coverage of DHTs.
To ensure DHTs can be used effectively in medical practice, a more flexible and nontraditional approach to assessment, reimbursement, and payment determination is required.
近年来,数字健康技术(DHT)的引入呈爆炸式增长,这些技术有可能改善健康结果并降低医疗保健服务的成本。事实上,人们期望这些创新技术最终能够填补患者与医疗服务提供者护理模式之间的空白,并希望能够缓解医疗支出不断增加的趋势,但这一期望在包括韩国在内的许多国家都尚未实现。我们考察了韩国数字健康技术的报销覆盖决策制定情况。
我们考察了韩国数字健康技术的监管环境、卫生技术评估流程以及报销覆盖范围的确定。
我们确定了数字健康技术报销覆盖的具体挑战和机遇。
为确保数字健康技术能够在医疗实践中得到有效应用,需要采取更加灵活和非传统的评估、报销和支付决策方法。